Canagliflozin for the Treatment of Diabetic Kidney Disease and Implications for Clinical Practice: A Narrative Review
Crossref DOI link: https://doi.org/10.1007/s13300-020-00826-w
Published Online: 2020-05-13
Published Print: 2020-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kruger, Davida
Valentine, Virginia
Funding for this research was provided by:
Janssen Scientific Affairs, LLC
Article History
Received: 12 March 2020
First Online: 13 May 2020